EMERALD RESOURCES NL
ASX:EMRMaterialsToday’s holders own 97.8% of what they think they own, once every option and right converts.
Proposed issue pending; 2% of shares in the money
Minimal because 4 of its 6 signals are quiet.
EMERALD RESOURCES NL's ordinary share count stood at 663M as of October 2026, up 1.0% from September 2024. The company has not raised capital through any cash placement, rights issue or share purchase plan in the past 24 months. Options and rights on issue could convert into 15M new shares, equal to 2.3% of the current share count, of which 2.0% are in the money; the nearest expiry is in October 2027. The company's latest cash report is a half-year/annual report, not a quarterly; it shows non-negative net cash flow, so no funding-runway estimate is applicable. One proposed securities issue (Appendix 3B) is pending, with an expected issue date in November 2026.
Quick answers · 4
Is EMR raising capital?
Emerald Resources has 1 proposed issue of securities pending under Appendix 3B as at 28 Oct 2026.
How much placement capacity does EMR have left?
None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
When do EMR's options expire?
Unexercised options and rights equal 2.3% of Emerald Resources's shares on issue; the nearest expiry is Oct 2027.
How much has EMR's share count grown?
Emerald Resources has 663.4M shares on issue as at 28 Oct 2026, up 1.0% over 24 months according to its Appendix 2A filings.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 9 Oct 2026 | 2A · quoted issue | EMR : ORDINARY FULLY PAID | 663.4M | Appendix 2A |
| 9 Oct 2026 | 3H · cancellation | EMR : ORDINARY FULLY PAID | 663.2M | Appendix 3H |
| 9 Oct 2026 | 3G · unquoted | EMR : ORDINARY FULLY PAID | 663.2M | Appendix 3G |
| 29 Sept 2026 | 2A · quoted issue | EMR : ORDINARY FULLY PAID | 663.2M | Appendix 2A |
| 23 Sept 2026 | 2A · quoted issue | EMR : ORDINARY FULLY PAID | 663.1M | Appendix 2A |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
At $6.30 today, 11.1M securities are in the money (1.7% of shares on issue). No more priced supply until 1.25× today’s price, which takes it to 14.3M (2.2% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| EMRAN | Options | Price-triggered | $1.37 | 17 Oct 2027 | 1.2M | Filing |
| EMRAO | Options | Price-triggered | $1.94 | 13 Apr 2028 | 570k | Filing |
| EMRAQ | Options | Price-triggered | $2.84 | 12 Sept 2028 | 1.9M | Filing |
| EMRAR | Options | Price-triggered | $3.70 | 28 Feb 2029 | 1.0M | Filing |
| EMRAS | Options | Price-triggered | $3.51 | 21 Mar 2029 | 500k | Filing |
| EMRAT | Options | Price-triggered | $4.43 | 31 July 2029 | 3.2M | Filing |
| EMRAU | Options | Price-triggered | $4.72 | 30 Sept 2029 | 250k | Filing |
| EMRAV | Options | Price-triggered | $4.40 | 14 Aug 2030 | 2.5M | Filing |
| EMRAW | Options | Price-triggered | $8.27 | 4 Feb 2031 | 700k | Filing |
| EMRAX | Options | Price-triggered | $6.88 | 18 June 2031 | 650k | Filing |
| EMRAY | Options | Price-triggered | $6.63 | 3 Aug 2031 | 2.5M | Filing |
| — | Options | Price-triggered | $8.35 | 23 Sept 2031 | 200k | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
- EMRAPPrice-triggered250k securities → 017 Sept 2026 Appendix 2A
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 10 July 2026 | Michael Evans | Sell | — | 500k | — | $1.6M | 3Y notice |
| 9 July 2026 | Michael Evans | Sell | 401k | — | — | $545k | 3Y notice |
| 10 July 2025 | Michael Evans | Sell on-market | 600k | — | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.